Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 18 Nov 2021 for Atara Biotherapeutics, Inc., €50k. Read the official filing
Filing timeline
BuySaleJoe Newell
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joe Newell: trading record in brief
This profile gathers the share dealings of Joe Newell in Atara Biotherapeutics, Inc., where the filings describe the role as senior executive. The record holds 8 filings, for trades running from 17 May 2021 to 16 November 2021.
Every open-market trade on record is a sale: 6 sales worth €234k. Outside the open market, there are 2 option exercises.
On 18 November 2021 came the latest disclosure, an open-market sale for €50k in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joe Newell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,332 shares@ US$17.116913.2% of flowCommon StockSEC:0001567619-21-020780:0
3,500 shares@ US$12.159.8% of flowCommon StockSEC:0001567619-21-020653:0
10,500 shares@ US$12.1528.7% of flowCommon StockSEC:0001567619-21-017578:0
3,116 shares@ US$15.612110.8% of flowCommon StockSEC:0001567619-21-017260:0
3,500 shares@ US$15.0011.7% of flowCommon StockSEC:0001567619-21-016517:0
2,426 shares@ US$12.5326.8% of flowCommon StockSEC:0001567619-21-016150:0
2,453 shares@ US$14.557.7% of flowCommon StockSEC:0001209191-21-034430:0
3,500 shares@ US$15.0011.3% of flowCommon StockSEC:0001209191-21-033285:0
8 of 8 declarations
